Zoetis | ZTS - Ordinary Share Capital


Zoetis reported $420.35M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Align Technology USD 71.62M 1000 Jun/2026
Bayer EUR 982.42M 0 Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Dentsply International USD 200.3M 700K Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Henry Schein USD 111.92M 2.51M Jun/2026
Idexx Laboratories USD 79.24M 611K Mar/2026
Illumina USD 151.3M 607K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Laboratory Of America USD 80.9M 1.4M Jun/2026
Merck USD 2.47B 4.93M Mar/2026
Neogen USD 217.7M 27K Mar/2026
Pacira USD 39.31M 1.81M Mar/2026
Perrigo USD 138.1M 500K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Quest Diagnostics USD 110M 1000K Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Sanofi EUR 1.2B 16.88M Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026